These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18378365)

  • 1. The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.
    Wang S; Zhang C; Zhang L; Li J; Huang Z; Lu S
    Vaccine; 2008 Apr; 26(17):2100-10. PubMed ID: 18378365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.
    Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL
    Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus.
    Xu K; Ling ZY; Sun L; Xu Y; Bian C; He Y; Lu W; Chen Z; Sun B
    Viral Immunol; 2011 Feb; 24(1):45-56. PubMed ID: 21319978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
    Zheng L; Wang F; Yang Z; Chen J; Chang H; Chen Z
    BMC Infect Dis; 2009 Feb; 9():17. PubMed ID: 19216752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
    Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
    J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroporation at low voltages enables DNA vaccine to provide protection against a lethal H5N1 avian influenza virus challenge in mice.
    Zhou Y; Fang F; Chen J; Wang H; Chang H; Yang Z; Chen Z
    Intervirology; 2008; 51(4):241-6. PubMed ID: 18812697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens.
    Shan S; Jiang Y; Bu Z; Ellis T; Zeng X; Edwards J; Tian G; Li Y; Ge J; Chen H; Fenwick S
    J Virol Methods; 2011 May; 173(2):220-6. PubMed ID: 21333689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant effect of CD40 on H5N1 DNA vaccine in mice.
    Chen Q; Zhu G; Wang R; Zhang J; He G
    Arch Virol; 2014 Jun; 159(6):1359-64. PubMed ID: 24357081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of the immunization with the sequence close to the consensus sequence and two DNA prime plus one VLP boost generate H5 hemagglutinin specific broad neutralizing antibodies.
    Wang G; Yin R; Zhou P; Ding Z
    PLoS One; 2017; 12(5):e0176854. PubMed ID: 28542275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
    Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
    J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation.
    Kadowaki S; Chen Z; Asanuma H; Aizawa C; Kurata T; Tamura S
    Vaccine; 2000 Jun; 18(25):2779-88. PubMed ID: 10812219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial.
    Kreijtz JH; Goeijenbier M; Moesker FM; van den Dries L; Goeijenbier S; De Gruyter HL; Lehmann MH; Mutsert Gd; van de Vijver DA; Volz A; Fouchier RA; van Gorp EC; Rimmelzwaan GF; Sutter G; Osterhaus AD
    Lancet Infect Dis; 2014 Dec; 14(12):1196-207. PubMed ID: 25455987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus h5 DNA vaccination is immunogenic by intramuscular and intradermal routes in humans.
    Ledgerwood JE; Hu Z; Gordon IJ; Yamshchikov G; Enama ME; Plummer S; Bailer R; Pearce MB; Tumpey TM; Koup RA; Mascola JR; Nabel GJ; Graham BS;
    Clin Vaccine Immunol; 2012 Nov; 19(11):1792-7. PubMed ID: 22956656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Stachyra A; Pietrzak M; Macioła A; Protasiuk A; Olszewska M; Śmietanka K; Minta Z; Góra-Sochacka A; Kopera E; Sirko A
    Virus Res; 2017 Mar; 232():41-47. PubMed ID: 28159612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle.
    Lin F; Shen X; McCoy JR; Mendoza JM; Yan J; Kemmerrer SV; Khan AS; Weiner DB; Broderick KE; Sardesai NY
    Vaccine; 2011 Sep; 29(39):6771-80. PubMed ID: 21199706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
    Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic mechanisms of DNA-raised antibody responses to intramuscular and gene gun immunizations.
    Boyle CM; Robinson HL
    DNA Cell Biol; 2000 Mar; 19(3):157-65. PubMed ID: 10749168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Construction and immunogenicity study of DNA vaccine expressing human H5N1 influenza virus hemagglutinin].
    Huan LF; Yao LH; Chen AJ; Cheng CS; Jia RQ; Tian Q; Bo H; Guo JQ; Wang M; Shu YL; Zhang ZQ
    Bing Du Xue Bao; 2007 Sep; 23(5):366-70. PubMed ID: 17969853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.